Efficacy of levodopa therapy on motor function after posteroventral pallidotomy for Parkinsons disease
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor:
We read with interest the article by Uitti et al. on the efficacy of levodopa therapy on motor function in 41 patients with complicated PD submitted to microelectrode-guided pallidotomy.1 The authors found no significant change in the latency, duration, or magnitude of clinical response after administration of an acute challenge of levodopa. However, it is difficult to understand how the magnitude of the clinical response remained unchanged after surgery. This pharmacologic parameter is defined as the difference between basal “off” and best “on” Unified Parkinson’s Disease Rating Scale (UPDRS) motor scores. Many reports confirm that pallidotomy provides marked contralateral amelioration of parkinsonian symptoms, and after surgery patients reported less recognizable “on-off” fluctuations.
Current ideas about the pathophysiologic basis of motor fluctuations suggest that the magnitude of the motor response is the key factor in the development of the wearing-off phenomenon.2 The improvement in motor fluctuations after pallidotomy is most likely due to a reduction in the magnitude of the motor response as a result of reduced severity of the parkinsonian signs and symptoms in the operated side. Indeed, Uitti et al. noted that the mean motor “off” score after pallidotomy was improved by 10 points (48.7 versus 38.6). The best motor “on” score was also improved, although to a lesser degree (24.6 versus 20.1). Despite this improvement in both scores, the magnitude of the motor response should be reduced after surgery because the degree of improvement in the “off” score is bigger than that obtained in the best “on” score. Other groups, despite methodologic differences, have found a significant reduction in the magnitude and an increase in the duration of the clinical benefit after acute levodopa and apomorphine challenges.3-5
We evaluated six patients with PD who underwent pallidotomy. The magnitude was reduced …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Fabricio Ferreira de Oliveira and Dr. Alan Cronemberger Andrade
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Expedited Publication
Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's diseaseR. Kumar, A. M. Lozano, Y. J. Kim et al.Neurology, September 01, 1998 -
Brief Communications
Efficacy of levodopa therapy on motor function after posteroventral pallidotomy for Parkinson's diseaseRyan J. Uitti, Robert E. Wharen, Jr, Margaret F. Turk et al.Neurology, December 01, 1998 -
Articles
Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulationR. Kumar, A.M. Lozano, E. Sime et al.Neurology, August 01, 1999 -
Articles
Subthalamic nucleus stimulation modulates afferent inhibition in Parkinson diseaseA. Sailer, D. I. Cunic, G. O. Paradiso et al.Neurology, January 29, 2007